Kingsview Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30K Buy
+15,293
New +$35.9K ﹤0.01% 1319
2022
Q1
Sell
-8,346
Closed -$273K 919
2021
Q4
$273K Buy
8,346
+2,730
+49% +$110K 0.01% 768
2021
Q3
$230K Buy
+5,616
New +$204K 0.01% 763

Other funds holding GDRX

Kingsview Wealth Management's GDRX Position: Q1 2026 in Review

Kingsview Wealth Management opened a new position in GoodRx Holdings (GDRX) in Q1 2026: 15,293 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #1319 among its holdings. This is a return to the name: Kingsview Wealth Management previously reported a position in GDRX as recently as Q4 2021.

Kingsview Wealth Management first reported a position in GDRX in Q3 2021 and has held it in 3 quarters since. The position peaked at $273K in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Kingsview Wealth Management held 15,293 shares of GoodRx Holdings worth $30K as of Q1 2026.
  • GoodRx Holdings was a new Kingsview Wealth Management position in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #1319 holding.
  • Kingsview Wealth Management first reported a position in GoodRx Holdings in Q3 2021 and has held it in 3 quarters since.
  • Kingsview Wealth Management's GoodRx Holdings position peaked at $273K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.